HUMAN MESANGIAL CELLS ARE RESISTANT TO PRODUCTIVE INFECTION BY MULTIPLE STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2

被引:44
|
作者
ALPERS, CE
MCCLURE, J
BURSTEN, SL
机构
[1] UNIV WASHINGTON, SCH MED, DEPT MED, SEATTLE, WA 98195 USA
[2] VET ADM MED CTR, SEATTLE, WA 98108 USA
[3] BRISTOL MYERS SQUIBB PHARMACEUT RES INST, SEATTLE, WA USA
关键词
HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED NEPHROPATHY; MESANGIAL CELLS;
D O I
10.1016/S0272-6386(12)70120-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Human immunodeficiency virus-associated nephropathy (HIVAN) is a recognized clinical entity of unknown pathogenesis. A role for viral infection of renal cells in the initiation of this process at present is an intriguing but untested hypothesis. Studies in primate models of acquired immunodeficiency syndrome (AIDS) suggest that injury to the mesangial cell may be central to the sclerosing glomerular lesion characteristic of HIVAN. We therefore tested the infectibility of human mesangial cells (HMC) in vitro by a variety of strains of HIV chosen to include a spectrum of tropisms for different cell types. Productive infection of mesangial cells could not be demonstrated using any of the virus strains. Nonetheless, HIV infection of intrinsic renal cells remains an attractive area of inquiry for understanding the natural history of HIVAN. © 1992, National Kidney Foundation. All rights reserved. All rights reserved.
引用
收藏
页码:126 / 130
页数:5
相关论文
共 50 条
  • [1] INFECTION OF NONLYMPHOID CELLS BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 OR TYPE-2
    IKEUCHI, K
    KIM, S
    BYRN, RA
    GOLDRING, SR
    GROOPMAN, JE
    JOURNAL OF VIROLOGY, 1990, 64 (09) : 4226 - 4231
  • [2] ACQUIRED IMMUNODEFICIENCY WITHOUT EVIDENCE OF INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    LAURENCE, J
    SIEGAL, FP
    SCHATTNER, E
    GELMAN, IH
    MORSE, S
    LANCET, 1992, 340 (8814): : 273 - 274
  • [3] INFECTION OF MACACA-NEMESTRINA BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2
    MORTON, WR
    SCHMIDT, AM
    AGY, MB
    KATZE, MG
    FLOREY, MJ
    COREY, L
    FRUMKIN, LR
    OCHS, HD
    HU, SL
    MCCLURE, J
    BENVENISTE, RE
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S86 - S86
  • [4] THE SPECIFICITY OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 TRANSACTIVATOR IS DIFFERENT FROM THAT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    EMERMAN, M
    GUYADER, M
    MONTAGNIER, L
    BALTIMORE, D
    MUESING, MA
    EMBO JOURNAL, 1987, 6 (12): : 3755 - 3760
  • [5] IMMUNOPRECIPITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 GLYCOPROTEINS BY SERA POSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    ESPEJO, RT
    URIBE, P
    JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (09) : 2107 - 2110
  • [6] INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PEDERSEN, C
    DANISH MEDICAL BULLETIN, 1994, 41 (01) : 12 - 22
  • [7] INFECTION WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2
    MARKOVITZ, DM
    ANNALS OF INTERNAL MEDICINE, 1993, 118 (03) : 211 - 218
  • [8] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PRODUCTIVE INFECTION IN STAUROSPORINE-BLOCKED QUIESCENT CELLS
    ARANDAANZALDO, A
    VIZA, D
    FEBS LETTERS, 1992, 308 (02) : 170 - 174
  • [9] PREVALENCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 INFECTIONS IN NIGERIA
    OLALEYE, OD
    BERNSTEIN, L
    EKWEOZOR, CC
    SHENG, ZJ
    OMILABU, SA
    LI, XY
    SULLIVANHALLEY, J
    RASHEED, S
    JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (03): : 710 - 714
  • [10] CHARACTERIZATION OF FOSCARNET-RESISTANT STRAINS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TACHEDJIAN, G
    HOOKER, DJ
    GURUSINGHE, AD
    BAZMI, H
    DEACON, NJ
    MELLORS, J
    BIRCH, C
    MILLS, J
    VIROLOGY, 1995, 212 (01) : 58 - 68